Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
Survey of pharmacists on their roles and perceptions of outpatient parenteral antimicrobial therapy in the United StatesChristina G Rivera, Kristin C Mara, Monica V Mahoney, et al.Therapeutics and Clinical Risk Management|June 10, 2016
Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infectionsStephanie E Giancola, Monica V Mahoney, Tiffany E Bias, et al.Open Forum Infectious Diseases|August 13, 2020
Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 PandemicChristina G Rivera, Monica V Mahoney, Ryan W Stevens, et al.The Annals of Pharmacotherapy|December 11, 2008
Severe pseudomembranous colitis after moxifloxacin use: a case seriesJason C Gallagher, Jennifer K Du, Christina RosePharmacotherapy|April 23, 2013
Emergent renal dysfunction with colistin pharmacotherapyJulie M Collins, Kevin Haynes, Jason C GallagherPharmacotherapy|April 1, 2011
Empiric antifungal therapy in patients with febrile neutropeniaJenna J Ferrara, Conan MacDougall, Jason C GallagherOpen Forum Infectious Diseases|February 27, 2018
Potential Adverse Effects of Broad-Spectrum Antimicrobial Exposure in the Intensive Care UnitJenna Wiens, Graham M Snyder, Samuel Finlayson, et al.The Annals of Pharmacotherapy|May 9, 2017
Bezlotoxumab: Could This be the Answer for Clostridium difficile Recurrence?Ryan W Chapin, Tiffany Lee, Christopher McCoy, et al.Antimicrobial Agents and Chemotherapy|July 16, 2014
Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infectionsJason C Gallagher, Safia Kuriakose, Kevin Haynes, et al.Current Infectious Disease Reports|May 7, 2018
The Epidemiology, Evolution, and Treatment of KPC-Producing OrganismsAnn Marie Porreca, Kaede V Sullivan, Jason C GallagherPageof 9